COVID-19 vaccines

South Korea approves 1st domestically developed COVID vaccine

Reuters

This is AI generated summarization, which may have errors. For context, always refer to the full article.

South Korea approves 1st domestically developed COVID vaccine

PUBLIC USE. People wearing masks to prevent contracting the COVID-19 walk at a railway station in Seoul, South Korea, on March 5, 2022.

Kim Hong-Ji/Reuters

The SKYCovione vaccine is authorized for a two-dose regimen on people aged 18 or older, with shots given four weeks apart

SEOUL, South Korea – South Korea approved its first domestically developed COVID-19 vaccine, manufactured by SK bioscience Co Ltd, for general public use following positive clinical data, authorities said on Wednesday, June 29.

The SKYCovione vaccine was authorized for a two-dose regimen on people aged 18 or older, with shots given four weeks apart, according to the Ministry of Food and Drug Safety.

In a phase III clinical trial of 4,037 adults, SKYCovione induced neutralizing antibody responses against the SARS-CoV-2 parental strain, SK bioscience said in a statement.

It is not yet known how effective it is against Omicron and other COVID variants.

The vaccine was jointly developed by the University of Washington’s Institute for Protein Design, with the support of global drugmaker GlaxoSmithKline (GSK).

SK bioscience said it would seek authorizations for distribution of SKYCovione in other countries and through global vaccine sharing facility COVAX, and for emergency use listing at the World Health Organization.

South Korean authorities have agreed a 200 billion won ($155 million) deal to buy 10 million doses of the vaccine, which can be stored under normal refrigeration conditions, and previously said they expected it to be rolled out from the second half of the year.

SK bioscience is now looking into its possible use for booster shots, and planning trials for adolescents and children, it added.

Nearly 87% of South Korea’s 52 million population are fully vaccinated, with 65% having also had a booster shot, according to the Korea Disease Control and Prevention Agency data. – Rappler.com

$1 = 1,293.2800 won

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!